Picture of Torrent Pharmaceuticals logo

TORNTPHARM Torrent Pharmaceuticals Income Statement

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Torrent Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

2019
March 31st
2020
March 31st
2021
March 31st
2022
March 31st
2023
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
IAS
IAS
IAS
IAS
IAS
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue76,72879,39380,04885,08096,202
Cost of Revenue
Gross Profit53,51156,86857,69559,70667,925
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses66,64464,23361,76972,23674,847
Operating Profit10,08415,16018,27912,84421,355
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes5,61711,86615,26312,25918,472
Provision for Income Taxes
Net Income After Taxes4,3639,71912,5197,77212,452
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income4,36310,24712,5197,77212,452
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income4,36310,24712,5197,77212,452
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS21.228.8373236.5
Dividends per Share
Special Dividends per Share